Meryx's Seed VC - II Round

Meryx raised a round of funding on June 29, 2015.

Meryx develops novel Mer tyrosine kinase inhibitor therapeutics for critically ill patients in areas of cancer and other major unmet diseases.…

Articles about Meryx's Seed VC - II Round: